Тhe Safety Assessment of the Ultraviolet Scleral Crosslinking with Riboflavin/UVA in Experiment

The purpose is to evaluate the safety of the scleral crosslinking with riboflavin/ultraviolet A (UVA) in an experiment in vivo. Materials and methods. The study was carried out on 34 Chinchilla rabbits (68 eyes). The right eyes were crosslinked (34 eyes), the left eyes were served as controls (34 ey...

Full description

Bibliographic Details
Main Authors: M. N. Astrelin, V. K. Surkova
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2019-04-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/908
id doaj-61d10d37a6d3456292d740b41e0b3789
record_format Article
spelling doaj-61d10d37a6d3456292d740b41e0b37892021-07-29T08:55:27ZrusOphthalmology Publishing GroupOftalʹmologiâ 1816-50952019-04-01161S10811110.18008/1816-5095-2019-1S-108-111523Тhe Safety Assessment of the Ultraviolet Scleral Crosslinking with Riboflavin/UVA in ExperimentM. N. Astrelin0V. K. Surkova1Ufa Eye Research InstituteUfa Eye Research InstituteThe purpose is to evaluate the safety of the scleral crosslinking with riboflavin/ultraviolet A (UVA) in an experiment in vivo. Materials and methods. The study was carried out on 34 Chinchilla rabbits (68 eyes). The right eyes were crosslinked (34 eyes), the left eyes were served as controls (34 eyes). Scleral crosslinking (SCXL) was performed with sclera saturation with a photosensitizer (0.1 % aqueous solution of riboflavin) for 20 minutes and its subsequent irradiation with ultraviolet A (wavelength of 370 ± 5 nm, irradiance — 3 mW/cm2), total exposure time — 30 minutes (6 cycles of 5 minutes). The effect of the procedure on the anatomical and functional state of the eye layers was assessed with high-resolution optical coherent tomography (OCT) and electroretinography (ERG) before crosslinking, a day, 7 and 30 days after it. Results. OCT did not reveal any pathological changes after scleral crosslinking with riboflavin/UVA. The layers of the retina, choroid and sclera were clearly visualized. The performed morphometric analysis has showed the absence of statistically significant changes in the eye layers thickness after ultraviolet crosslinking. The amplitude-time characteristics and the shape of the electroretinogram of the experimental and control rabbits eyes were identical during all periods of observation, had a classic appearance. All waves of ERG were well expressed. It indicates a satisfactory functional state of the retinal neuroreceptor mechanisms. Conclusion. For ultraviolet crosslinking we used UVA with an irradiance of 3 mW/cm2 for 30 minutes and a 0.1 % aqueous solution of riboflavin without dextran and did not reveal any side effects of the procedure. Thus, scleral crosslinking with these parameters is safe for the eye layers in an experiment in vivo.https://www.ophthalmojournal.com/opht/article/view/908crosslinkingscleraexperimentoptical coherence tomography
collection DOAJ
language Russian
format Article
sources DOAJ
author M. N. Astrelin
V. K. Surkova
spellingShingle M. N. Astrelin
V. K. Surkova
Тhe Safety Assessment of the Ultraviolet Scleral Crosslinking with Riboflavin/UVA in Experiment
Oftalʹmologiâ
crosslinking
sclera
experiment
optical coherence tomography
author_facet M. N. Astrelin
V. K. Surkova
author_sort M. N. Astrelin
title Тhe Safety Assessment of the Ultraviolet Scleral Crosslinking with Riboflavin/UVA in Experiment
title_short Тhe Safety Assessment of the Ultraviolet Scleral Crosslinking with Riboflavin/UVA in Experiment
title_full Тhe Safety Assessment of the Ultraviolet Scleral Crosslinking with Riboflavin/UVA in Experiment
title_fullStr Тhe Safety Assessment of the Ultraviolet Scleral Crosslinking with Riboflavin/UVA in Experiment
title_full_unstemmed Тhe Safety Assessment of the Ultraviolet Scleral Crosslinking with Riboflavin/UVA in Experiment
title_sort тhe safety assessment of the ultraviolet scleral crosslinking with riboflavin/uva in experiment
publisher Ophthalmology Publishing Group
series Oftalʹmologiâ
issn 1816-5095
publishDate 2019-04-01
description The purpose is to evaluate the safety of the scleral crosslinking with riboflavin/ultraviolet A (UVA) in an experiment in vivo. Materials and methods. The study was carried out on 34 Chinchilla rabbits (68 eyes). The right eyes were crosslinked (34 eyes), the left eyes were served as controls (34 eyes). Scleral crosslinking (SCXL) was performed with sclera saturation with a photosensitizer (0.1 % aqueous solution of riboflavin) for 20 minutes and its subsequent irradiation with ultraviolet A (wavelength of 370 ± 5 nm, irradiance — 3 mW/cm2), total exposure time — 30 minutes (6 cycles of 5 minutes). The effect of the procedure on the anatomical and functional state of the eye layers was assessed with high-resolution optical coherent tomography (OCT) and electroretinography (ERG) before crosslinking, a day, 7 and 30 days after it. Results. OCT did not reveal any pathological changes after scleral crosslinking with riboflavin/UVA. The layers of the retina, choroid and sclera were clearly visualized. The performed morphometric analysis has showed the absence of statistically significant changes in the eye layers thickness after ultraviolet crosslinking. The amplitude-time characteristics and the shape of the electroretinogram of the experimental and control rabbits eyes were identical during all periods of observation, had a classic appearance. All waves of ERG were well expressed. It indicates a satisfactory functional state of the retinal neuroreceptor mechanisms. Conclusion. For ultraviolet crosslinking we used UVA with an irradiance of 3 mW/cm2 for 30 minutes and a 0.1 % aqueous solution of riboflavin without dextran and did not reveal any side effects of the procedure. Thus, scleral crosslinking with these parameters is safe for the eye layers in an experiment in vivo.
topic crosslinking
sclera
experiment
optical coherence tomography
url https://www.ophthalmojournal.com/opht/article/view/908
work_keys_str_mv AT mnastrelin thesafetyassessmentoftheultravioletscleralcrosslinkingwithriboflavinuvainexperiment
AT vksurkova thesafetyassessmentoftheultravioletscleralcrosslinkingwithriboflavinuvainexperiment
_version_ 1721250936142168064